20:36 19/01/2016 JPM Conference Takeaways: Maxim Analysts Offer Commentary On AEterna Zentaris ...
JPM Conference Takeaways: Maxim Analysts Offer Commentary On AEterna Zentaris ...
Smarter Analyst - Jan 19, 2016
Following the annual J.P. Morgan healthcare conference, Maxim analysts offered commentary on a handful of biotechnology stocks. Here are the primary takeaways the analysts offered on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) Kite Pharma Inc ...

14:48 19/01/2016 Aeterna Zentaris Inc. (USA) (AEZS) Shares Up over 30% on News of Successful ...
Aeterna Zentaris Inc. (USA) (AEZS) Shares Up over 30% on News of Successful ...
Independent Reporter - Jan 19, 2016
Aeterna Zentaris Inc. (USA) (NASDAQ:AEZS) is currently developing a new means of evaluating adult growth hormone deficiency (AGHD), which aims to be more successful and safer to use than the alternative insulin tolerance test (ITT), which is used by ...
Aeterna Zentaris Concludes Successful Meeting of Clinical Investigators for ... - Business Wire (press release)
4 Small Cap NASDAQ/NYSE Stocks That Are Trading with Heavy Volume Today - Baystreet.ca

16:21 02/12/2015 Canaccord Weighs In On AEterna Zentaris Inc. (USA) (AEZS) Following Co ...
Canaccord Weighs In On AEterna Zentaris Inc. (USA) (AEZS) Following Co ...
Smarter Analyst - Dec 2, 2015
Canaccord's healthcare analyst Neil Maruoka weighed in on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the company announced the finalization of a co-promotion agreement with Armune BioScience for APIFINY, a test for prostate cancer.
Aeterna Zentaris Rises on Finalized Marketing Agreement - 24/7 Wall St.

13:53 25/11/2015 Canaccord Adjusts Price Target For AEterna Zentaris Inc. (USA) (AEZS ...
Canaccord Adjusts Price Target For AEterna Zentaris Inc. (USA) (AEZS ...
Smarter Analyst - Nov 25, 2015
Canaccord analyst Neil Maruoka weighed in with a few insights on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS), following the completion of share consolidation at a conversion ratio of 100-to-1, which became effective on November 20.
AEterna Zentaris Inc. (USA) (AEZS) Making Another Monster Move Today - Insider Monkey (blog)
AEterna Zentaris Inc. (USA) (AEZS) Up Big Again Following Pivotal Phase 3 Gets ... - Independent Reporter

16:45 23/11/2015 Maxim Introduces New Price Target For AEterna Zentaris Inc. (USA) (AEZS) On ...
Maxim Introduces New Price Target For AEterna Zentaris Inc. (USA) (AEZS) On ...
Smarter Analyst - Nov 23, 2015
In a research report released today, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc.
Hot Stock List: Aeterna Zentaris (NASDAQ:AEZS), Vanguard Natural Resources ... - Benchmark Monitor

20:17 10/11/2015 Here's Why Canaccord Upgraded AEterna Zentaris Inc. (USA) (AEZS) to ...
Here's Why Canaccord Upgraded AEterna Zentaris Inc. (USA) (AEZS) to ...
Smarter Analyst - Nov 10, 2015
In a research report published yesterday, Canaccord analyst Neil Maruoka upgraded shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) from a Hold to a Speculative Buy rating, while reducing the price target to $0.10 (from $0.15), which represents a ...

21:22 06/11/2015 Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 3Q Update
Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 3Q Update
Smarter Analyst - Nov 6, 2015
In a research report published Friday, Maxim Group analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a $2.00 price target, following the company's third-quarter financial results and update on its ...

16:57 13/10/2015 Maxim Weighs In On AEterna Zentaris Inc. (USA) (AEZS) As The DSMB Recommends ...
Maxim Weighs In On AEterna Zentaris Inc. (USA) (AEZS) As The DSMB Recommends ...
Smarter Analyst - Oct 13, 2015
Maxim Group analyst Jason Kolbert came out today with a few insights on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS), after the company announced that the independent Data and Safety Monitoring Board (DSMB) gave the approval to continue the pivotal ...

20:47 28/09/2015 Maxim Weighs In On AEterna Zentaris Inc. (USA) Following Positive Clinical ...
Maxim Weighs In On AEterna Zentaris Inc. (USA) Following Positive Clinical ...
Smarter Analyst - Sep 28, 2015
In a research report issued today, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a $2 price target, after the company announced that its lead oncology compound, zoptarelin doxorubicin ...
AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) Gets TSX Approval of Series 'B ... - Journal Transcript
Aeterna Zentaris' Zoptarelin Doxorubicin Meets Phase 2 Primary Endpoint in Men ... - PR Newswire (press release)

15:57 17/08/2015 Canaccord Slashes Price Target for AEterna Zentaris Inc. (USA) on Back of ...
Canaccord Slashes Price Target for AEterna Zentaris Inc. (USA) on Back of ...
Smarter Analyst - Aug 17, 2015
In a research report released Monday, Canaccord analyst Neil Maruoka maintained a Hold rating on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) and reduced the price target to $0.15 (from $0.70), citing substantial dilution risk. Maruoka noted, ‚ÄúDuring the ...
Biotech Stocks with Pessimistic Trend: AEterna Zentaris Inc. (USA) (NASDAQ ... - Wall Street Point